Trial · NCT02157935
Adverse events152
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 152
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Formoterol 4.5 ug x2 Bid | 32 | 613 | 35 |
| other | Nasopharyngitis | Infections and infestations | Symbicort 160/4.5 ug x2 Bid | 30 | 605 | 34 |
| other | Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | Formoterol 4.5 ug x2 Bid | 27 | 613 | 31 |
| other | Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | Symbicort 160/4.5 ug x2 Bid | 8 | 605 | 8 |
| serious | Anaemia | Blood and lymphatic system disorders | Formoterol 4.5 ug x2 Bid | 1 | 613 | 1 |
| serious | Anaemia | Blood and lymphatic system disorders | Symbicort 160/4.5 ug x2 Bid | 0 | 605 | 0 |
| serious | Retroperitoneal lymphadenopathy | Blood and lymphatic system disorders | Formoterol 4.5 ug x2 Bid | 0 | 613 | 0 |
| serious | Retroperitoneal lymphadenopathy | Blood and lymphatic system disorders | Symbicort 160/4.5 ug x2 Bid | 1 | 605 | 1 |
| serious | Acute coronary syndrome | Cardiac disorders | Formoterol 4.5 ug x2 Bid | 1 | 613 | 1 |
| serious | Acute coronary syndrome | Cardiac disorders | Symbicort 160/4.5 ug x2 Bid | 0 | 605 | 0 |
| serious | Angina pectoris | Cardiac disorders | Formoterol 4.5 ug x2 Bid | 2 | 613 | 2 |
| serious | Angina pectoris | Cardiac disorders | Symbicort 160/4.5 ug x2 Bid | 2 | 605 | 2 |
| serious | Atrial fibrillation | Cardiac disorders | Formoterol 4.5 ug x2 Bid | 1 | 613 | 1 |
| serious | Atrial fibrillation | Cardiac disorders | Symbicort 160/4.5 ug x2 Bid | 1 | 605 | 1 |
| serious | Cardiac arrest | Cardiac disorders | Formoterol 4.5 ug x2 Bid | 0 | 613 | 0 |
| serious | Cardiac arrest | Cardiac disorders | Symbicort 160/4.5 ug x2 Bid | 1 | 605 | 1 |
| serious | Cardiac failure | Cardiac disorders | Formoterol 4.5 ug x2 Bid | 2 | 613 | 3 |
| serious | Cardiac failure | Cardiac disorders | Symbicort 160/4.5 ug x2 Bid | 0 | 605 | 0 |
| serious | Cardiac failure acute | Cardiac disorders | Formoterol 4.5 ug x2 Bid | 0 | 613 | 0 |
| serious | Cardiac failure acute | Cardiac disorders | Symbicort 160/4.5 ug x2 Bid | 1 | 605 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02157935/events